From: Increased pulmonary embolism in patients with COVID-19: a case series and literature review
Test Name | Unit | Reference Range | Case 1 | Case 2 | Case 3 |
---|---|---|---|---|---|
BUN | mg/dl | 7–16.8 | 24 Hi | 28 Hi | 20 |
Ca | mg/dl | 8.6–10.3 | 8.5 Low | – | – |
p | mg/dl | 2.7–4.5 | 4.9 Hi | – | – |
Na (ser) | mEq/L | 138–145 | 139 | 139 | 140 |
K (ser) | mEq/L | 3.6–5.9 | 4.3 | 4.3 | 3.7 |
MCH | pg | 27.5–33.2 | 28.2 | 28.2 | 32.5 |
MCHC | g/dL | 30.0–38.0 | 34.6 | 31.6 | 32.6 |
Plt | × 1000/μL | 140–440 | 252 | 167 | 72 |
Cr | mg/dl | male:0.8–1.3 mg/dl | 1 | 1.1 | 1.4 Hi |
SGOT (AST) | IU/L | Male:< 40 | 86 Hi | 109 Hi | – |
SGPT (ALT) | IU/L | Male:< 45 | 46 Hi | 55 Hi | – |
WBC | ×1000/μL | 4.4–11 | 3.5 Low | 8.6 | 8 |
RBC | ×1,000,000/μL | male:4.5–6.5 | 4.25 Low | 4.04 Low | 4.19 Low |
Hb | g/dl | male:14–17 | 12 Low | 14.2 | 13.6 Low |
Hct | % | male:41.5–50.4 | 34.7 Low | 45.0 | 41.7 |
MCV | fl | 80–96 | 81.6 | 89.3 | 99.5 |
ALK.P | IU/L | Male:0–270 | 617 Hi | 280 Hi | – |
CRP | mg/L | 0–6 | – | 65 Hi | – |
ESR | mm | 5–12 | – | 55 Hi | – |
D-Dimer | ng/ml | Normal< 200 | – | < 200 | – |
CPK | IU/L | Male:0–171 | 617 Hi | – | 350 Hi |
LDH | U/L | Male:235–470 | 810 Hi | – | 650 Hi |
Troponin 1 |  |  | Negative | – | Negative |
BS | mg/dl |  | 126 | – | 127 |
P.T.T | sec | 26–38 s | 29 | – | 30 |
PT |  | 11–13 s | 13.6 | – | 15 |
INR |  |  | 1.2 | – | 1.6 |
PT Control | % |  | 12 | – | 11 |
Amylase | IU/L | < 100 U/L | 98 | – | – |
HBSAg CLIA | MIU/ml | < 1 non reactive> = 1 reactive | Negative | Negative | Negative |
HCV-Ab CLIA | MIU/ml | < 1 non reactive> = 1 reactive | Negative | Negative | Negative |
HIV-Ab CLIA | MIU/ml | < 1 non reactive> = 1 reactive | Negative | Negative | Negative |